Endologix, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 24.841 million compared to USD 36.238 million a year ago. Operating loss was USD 17.349 million compared to USD 9.867 million a year ago. Net loss was USD 26.093 million compared to USD 27.134 million a year ago. Basic loss per share was USD 1.26 compared to USD 1.5 a year ago. For the half year, sales was USD 53.351 million compared to USD 71.844 million a year ago. Operating loss was USD 33.533 million compared to USD 21.861 million a year ago. Net loss was USD 44.208 million compared to USD 49.162 million a year ago. Basic loss per share was USD 2.17 compared to USD 3.44 a year ago.